- Home
- AKTX vs OTLK Comparison
AKTX vs OTLK Comparison
Compare AKTX & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- OTLK
- Stock Information
- Founded
- AKTX N/A
- OTLK 2010
- Country
- AKTX United States
- OTLK United States
- Employees
- AKTX N/A
- OTLK N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AKTX Health Care
- OTLK Health Care
- Exchange
- AKTX Nasdaq
- OTLK Nasdaq
- Market Cap
- AKTX 29.5M
- OTLK 35.0M
- IPO Year
- AKTX N/A
- OTLK 2016
- Fundamental
- Price
- AKTX $0.99
- OTLK $1.50
- Analyst Decision
- AKTX
- OTLK Strong Buy
- Analyst Count
- AKTX 0
- OTLK 7
- Target Price
- AKTX N/A
- OTLK $40.57
- AVG Volume (30 Days)
- AKTX 91.8K
- OTLK 4.6M
- Earning Date
- AKTX 02-15-2025
- OTLK 02-12-2025
- Dividend Yield
- AKTX N/A
- OTLK N/A
- EPS Growth
- AKTX N/A
- OTLK N/A
- EPS
- AKTX N/A
- OTLK N/A
- Revenue
- AKTX N/A
- OTLK N/A
- Revenue This Year
- AKTX N/A
- OTLK N/A
- Revenue Next Year
- AKTX N/A
- OTLK N/A
- P/E Ratio
- AKTX N/A
- OTLK N/A
- Revenue Growth
- AKTX N/A
- OTLK N/A
- 52 Week Low
- AKTX $0.90
- OTLK $0.87
- 52 Week High
- AKTX $4.40
- OTLK $12.85
- Technical
- Relative Strength Index (RSI)
- AKTX 31.38
- OTLK 21.72
- Support Level
- AKTX $0.95
- OTLK $1.35
- Resistance Level
- AKTX $1.13
- OTLK $1.65
- Average True Range (ATR)
- AKTX 0.15
- OTLK 0.22
- MACD
- AKTX 0.02
- OTLK 0.03
- Stochastic Oscillator
- AKTX 15.15
- OTLK 14.03
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.